Consistent with an important role of ERBB2 in breast cancer metastasis, overexpression of a constitutively activated form of ERBB2 (i.e. NeuT) [14] in mice is sufficient to trigger metastatic mammary tumors [15]. Here, ERBB2 is linked to breast carcinoma.